Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Dacthal Birth Defect Risks Lead EPA To Finalize Ban on Use, Sale or Distribution of Weedkiller All use of Dacthal is immediately prohibited, and the manufacturer has a plan to collect all existing stock of the weedkiller, EPA officials say. October 24, 2024 Irvin Jackson Add Your Comments The pesticide Dacthal has officially been removed from the market in the United States, after federal regulators determined that it poses too great of a risk to unborn children, who may be left with severe birth defects. Dacthal is the brand name of Dimethyl Tetrachloroterephthalate (DCPA), which is a weedkiller made by AMVAC Chemical that has been widely used on vegetables like broccoli and onions. It is also often used on turfs, such as golf courses and athletic fields. However, after years of looking at data and scientific studies, the U.S. Environmental Protection Agency (EPA) determined earlier this year that pregnant women exposed to high levels of Dacthal face an unreasonably high risk of fetal thyroid hormone disruption. This can result in their child experiencing impaired brain development, impaired motor skills and low birth weight, among other Dacthal birth defect risks. Although the European Union banned the use of Dacthal in 2009, it has remained on the market in the United States. In August 2024, the EPA finally issued an emergency Dacthal recall order, suspending all DCPA use permits. It was the first time the EPA had taken such an extreme act to remove a pesticide from the market in nearly 40 years, and the agency finalized the ban this week, canceling use permits for all products containing Dacthal. PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION PARAQUAT Parkinson’s Lawsuits Were you or a loved one exposed to Paraquat? Lawyers are reviewing Paraquat lawsuits for individuals who were exposed to Paraquat and developed Parkinson’s disease. Learn More SEE IF YOU QUALIFY FOR COMPENSATION In an October 22 press release announcing the final Dacthal (DCPA) cancellation, the EPA indicates that the decision came from an analysis of the best available science, including “robust” studies showing the fetal thyroid hormonal effects and unjustifiable risk of birth defects for unborn children. “With the final cancellation of DCPA, we’re taking a definitive step to protect pregnant women and their unborn babies,” Michal Freedhoff, assistant administrator of the EPA Office of Chemical Safety and Pollution Prevention, said in the press release. “The science showing the potential for irreversible harm to unborn babies’ developing brains, in addition to other lifelong consequences from exposure, demands decisive action to remove this dangerous chemical from the marketplace.” Years of Dacthal Birth Defect Concerns EPA scientists began expressing concern about the safety of the weedkiller as early as 1999, when studies on rats revealed Dacthal’s effects on thyroid function. The agency then requested the manufacturer, AMVAC, submit additional data on the potential Dacthal birth defect risks. AMVAC submitted some of the data in May 2021, but EPA officials said the report did not satisfy the agency’s data requirements. The agency issued a Notice of Intent to suspend Dacthal approval in April 2022, and the company finally submitted the data EPA requested that August. After assessments earlier this year by the EPA, AMVAC and the agency discussed how to limit exposure to the chemical, with the manufacturer submitting proposals in April and May. However, even agreements to limit exposure in residential use were not enough to alleviate the risk of birth defects from Dacthal, the EPA determined. Following the EPA’s emergency order, AMVAC sent the agency a letter indicating its plans to voluntarily cancel the remaining Dacthal products on the market in the U.S. and around the world, according to the agency. However, while cooperating, American Vanguard officials expressed doubts about Dacthal health risks, which the company claimed were based off “one rat study.” “While the Company continues to question EPA’s conclusions in support of the suspension, we believe that the best course of action is to voluntarily cancel registrations of this product,” AMVAC officials stated in an August 21 press release.” We are working apace with both state and federal authorities to effect product return and to remove Dacthal from channels of distribution. It is the Company’s position that product stewardship be international in scope; thus, we will now proceed to voluntarily cancel all international registrations as well.” The EPA published a Federal Register notice on August 29, announcing AMVAC’s voluntary cancellation and requesting public comments. The period for accepting public comments ended, resulting in Tuesday’s announcement. Permanent Dacthal Ban Effective Immediately According to the EPA, Dacthal’s final cancellation “prohibits anyone from distributing, selling or carrying out other similar activities for the remaining pesticide products containing DCPA.” No one is allowed to continue using existing stocks of the herbicide either. AMVAC has a voluntary return program in place for Dacthal products still on the market, in inventories, or being used by customers, according to the agency. The EPA says the company also has a plan to identify those individuals or companies with existing stocks and has coordinated a collection process. The agency indicates it will continue to monitor the return process to ensure that the weedkiller is collected and disposed of properly. The final cancellation of the weedkiller comes as the manufacturer already faces a number of potential Dacthal birth defect lawsuits being investigated by families of children left with brain development or motor development problems after mothers were exposed to the chemical during pregnancy. Tags: Children, Dacthal, DCPA, Developmental Disorders, EPA, Herbicide, Low Birth Weight, Pregnancy, Thyroid, Thyroid Disease, Weed Killer Image Credit: Shutterstock More Paraquat Lawsuit Stories MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 May 16, 2025 Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL April 16, 2025 Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials February 14, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (Posted: today) After a growing body of evidence has linked use of the Depo-Provera birth control shot to an increased risk of brain tumors, thousands of women nationwide are seeking information on how to sign up for the Depo-Provera lawsuit. MORE ABOUT: DEPO-PROVERA LAWSUITCourt Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025) Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: yesterday) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025) Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: 2 days ago) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)
Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials February 14, 2025
Depo-Provera Lawsuit Sign Ups Expected To Continue as First Brain Tumor Cases Prepared for Trial (Posted: today) After a growing body of evidence has linked use of the Depo-Provera birth control shot to an increased risk of brain tumors, thousands of women nationwide are seeking information on how to sign up for the Depo-Provera lawsuit. MORE ABOUT: DEPO-PROVERA LAWSUITCourt Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (05/15/2025)Depo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)
Lawyers To Select 50 Suboxone Dental Lawsuits for Next Phase of MDL Bellwether Discovery (Posted: yesterday) As lawyers continue to review records on more than 500 Suboxone tooth decay lawsuits, the MDL judge has outlined the process for identifying a smaller group that will move into the next discovery phase. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUIT500 Suboxone Tooth Decay Cases Randomly Selected for Bellwether Record Collection Pool (04/24/2025)Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (04/16/2025)Prenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)
Hair Relaxer Lawsuits MDL Judge Seeks Status Report on Discovery Proceedings (Posted: 2 days ago) A federal judge wants lawyers involved in hair relaxer lawsuits to provide an update this week on the status of discovery proceedings for a pool of cases being considered for bellwether trial dates. MORE ABOUT: HAIR RELAXER LAWSUITFormaldehyde Found in Range of Personal Care Products Used Primarily by Black and Latina Women (05/14/2025)Lawyers Selected 32 Hair Relaxer Lawsuits for Bellwether Discovery in MDL (05/13/2025)Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (04/29/2025)